Mumbai, August 19, 2025 Gem Aromatics Ltd., a leading manufacturer of aroma chemicals and specialty ingredients, saw its ₹451 crore initial public offering (IPO) fully subscribed within hours of opening. The strong Day 1 response underscores investor appetite for niche chemical players with global linkages and consumer-facing applications.
Subscription Snapshot
| Category | Subscription Status |
| Retail Individual Investors | 1.08× |
| Qualified Institutional Buyers (QIBs) | 1.05× |
| Non-Institutional Investors (NIIs) | 0.88× |
| Retail Individual Investors | 1.08× |
| Qualified Institutional Buyers (QIBs) | 1.05× |
The IPO, priced between ₹309–₹325 per share, includes a fresh issue of ₹135 crore and an offer-for-sale of ₹316 crore. Ahead of the public issue, Gem raised ₹135 crore from anchor investors including Goldman Sachs, Citigroup Global, Societe Generale, Nippon India, and others.
Business Overview
Gem Aromatics specializes in fragrance intermediates, aroma molecules, and essential oils used across personal care, food, and pharma sectors. Its client roster includes Colgate-Palmolive, Dabur, Patanjali, Symrise, and several global flavor houses.
With manufacturing facilities in Gujarat and R&D partnerships in Europe, the company is positioning itself as a scalable export-oriented player in the value-added chemical segment.
Why Investors Are Interested
- Consumer Linkage: Products feed into FMCG and pharma supply chains, offering recession-resistant demand.
- Global Exposure: Exports account for over 40% of revenue, with regulatory approvals in EU and US.
- Margin Profile: Specialty chemicals typically command higher margins than bulk chemicals.
- Anchor Confidence: Participation from marquee funds signals institutional trust.
What’s Next?
The IPO closes on August 21, with listing expected on August 26. Market watchers will be keen to see if Day 2 and Day 3 bring oversubscription, especially from NIIs and QIBs
Want to get more such updates stay ahead of upcoming IPOs and read more such type of content? Subscribe to our newsletter for weekly IPO alerts, allotment updates, and expert analysis tailored for smart investors.